168 related articles for article (PubMed ID: 16562590)
1. Pamidronate treatment of steroid associated osteonecrosis in young patients treated for acute lymphoblastic leukaemia--two-year outcomes.
Nguyen T; Zacharin MR
J Pediatr Endocrinol Metab; 2006 Feb; 19(2):161-7. PubMed ID: 16562590
[TBL] [Abstract][Full Text] [Related]
2. Use of bisphosphonates for the treatment of osteonecrosis as a complication of therapy for childhood acute lymphoblastic leukaemia (ALL).
Kotecha RS; Powers N; Lee SJ; Murray KJ; Carter T; Cole C
Pediatr Blood Cancer; 2010 Jul; 54(7):934-40. PubMed ID: 20127847
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of pamidronate as treatment of symptomatic osteonecrosis occurring in children treated for acute lymphoblastic leukemia.
Leblicq C; Laverdière C; Décarie JC; Delisle JF; Isler MH; Moghrabi A; Chabot G; Alos N
Pediatr Blood Cancer; 2013 May; 60(5):741-7. PubMed ID: 23002054
[TBL] [Abstract][Full Text] [Related]
4. QUESTION 1: Should we be using bisphosphonates for osteonecrosis complicating childhood acute lymphoblastic leukaemia?
Amin NL; James RM; Phillips R
Arch Dis Child; 2016 Mar; 101(3):287-90. PubMed ID: 26768828
[No Abstract] [Full Text] [Related]
5. Bisphosphonate treatment in children with acute lymphoblastic leukemia and osteonecrosis - radiological and clinical findings in a national cohort.
Utriainen P; Niinimäki TT; Huurre AJ; Vepsäläinen KL; Mäkitie OM; Niinimäki RA
Acta Oncol; 2021 Sep; 60(9):1140-1145. PubMed ID: 34309491
[No Abstract] [Full Text] [Related]
6. Possible beneficial effect of bisphosphonates in osteonecrosis of the knee.
Kraenzlin ME; Graf C; Meier C; Kraenzlin C; Friedrich NF
Knee Surg Sports Traumatol Arthrosc; 2010 Dec; 18(12):1638-44. PubMed ID: 20376625
[TBL] [Abstract][Full Text] [Related]
7. Does Zoledronate Prevent Femoral Head Collapse from Osteonecrosis? A Prospective, Randomized, Open-Label, Multicenter Study.
Lee YK; Ha YC; Cho YJ; Suh KT; Kim SY; Won YY; Min BW; Yoon TR; Kim HJ; Koo KH
J Bone Joint Surg Am; 2015 Jul; 97(14):1142-8. PubMed ID: 26178889
[TBL] [Abstract][Full Text] [Related]
8. Acetabular avascular necrosis following high-dose steroid treatment and chemotherapy for leukemia : Computer tomography analysis of treatment with impaction bone grafting.
Chou DTS; Taylor M; Baker M; Studer P; Solomon LB
Skeletal Radiol; 2020 Jan; 49(1):147-154. PubMed ID: 31139921
[TBL] [Abstract][Full Text] [Related]
9. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
Bamias A; Kastritis E; Bamia C; Moulopoulos LA; Melakopoulos I; Bozas G; Koutsoukou V; Gika D; Anagnostopoulos A; Papadimitriou C; Terpos E; Dimopoulos MA
J Clin Oncol; 2005 Dec; 23(34):8580-7. PubMed ID: 16314620
[TBL] [Abstract][Full Text] [Related]
10. Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL).
Padhye B; Dalla-Pozza L; Little D; Munns C
Cancer Med; 2016 May; 5(5):960-7. PubMed ID: 26792372
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate Therapy for Treating Osteonecrosis in Pediatric Leukemia Patients: A Systematic Review.
Daneshdoost SM; El Abiad JM; Ruble KJ; Jones LC; Crane JL; Morris CD; Levin AS
J Pediatr Hematol Oncol; 2021 Apr; 43(3):e365-e370. PubMed ID: 32324697
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonates in multiple myeloma: a network meta-analysis.
Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B
Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688
[TBL] [Abstract][Full Text] [Related]
13. Pamidronate in patients with painful bone metastases, who failed initial treatment with hormones and/or chemotherapy.
Cascinu S; Casadei V; Del Ferro E; Alessandroni P; Catalano G
Support Care Cancer; 1996 Jan; 4(1):31-3. PubMed ID: 8771291
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonates for Paget's disease of bone in adults.
Corral-Gudino L; Tan AJ; Del Pino-Montes J; Ralston SH
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD004956. PubMed ID: 29192423
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies.
Boonyapakorn T; Schirmer I; Reichart PA; Sturm I; Massenkeil G
Oral Oncol; 2008 Sep; 44(9):857-69. PubMed ID: 18282788
[TBL] [Abstract][Full Text] [Related]
16. High-dose intravenous pamidronate for metastatic bone pain.
Purohit OP; Anthony C; Radstone CR; Owen J; Coleman RE
Br J Cancer; 1994 Sep; 70(3):554-8. PubMed ID: 8080746
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate combination therapy for non-femoral avascular necrosis.
Agarwala S; Vijayvargiya M
J Orthop Surg Res; 2019 Apr; 14(1):112. PubMed ID: 31018848
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonates and other bone agents for breast cancer.
Wong MH; Stockler MR; Pavlakis N
Cochrane Database Syst Rev; 2012 Feb; (2):CD003474. PubMed ID: 22336790
[TBL] [Abstract][Full Text] [Related]
19. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP
J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
[TBL] [Abstract][Full Text] [Related]
20. Pamidronate therapy for preventing steroid-induced osteoporosis in children with nephropathy.
Kim SD; Cho BS
Nephron Clin Pract; 2006; 102(3-4):c81-7. PubMed ID: 16282699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
